- Home
- PHM vs WST Comparison
PHM vs WST Comparison
Compare PHM & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHM
- WST
- Stock Information
- Founded
- PHM 1950
- WST 1923
- Country
- PHM United States
- WST United States
- Employees
- PHM N/A
- WST N/A
- Industry
- PHM Homebuilding
- WST Medical/Dental Instruments
- Sector
- PHM Consumer Discretionary
- WST Health Care
- Exchange
- PHM Nasdaq
- WST Nasdaq
- Market Cap
- PHM 27.0B
- WST 18.9B
- IPO Year
- PHM N/A
- WST N/A
- Fundamental
- Price
- PHM $134.10
- WST $256.66
- Analyst Decision
- PHM Buy
- WST Strong Buy
- Analyst Count
- PHM 14
- WST 8
- Target Price
- PHM $136.71
- WST $329.43
- AVG Volume (30 Days)
- PHM 2.0M
- WST 539.7K
- Earning Date
- PHM 10-21-2025
- WST 10-23-2025
- Dividend Yield
- PHM 0.66%
- WST 0.34%
- EPS Growth
- PHM 2.26
- WST N/A
- EPS
- PHM 13.40
- WST 6.68
- Revenue
- PHM $17,694,541,000.00
- WST $2,960,200,000.00
- Revenue This Year
- PHM N/A
- WST $6.28
- Revenue Next Year
- PHM $0.08
- WST $6.02
- P/E Ratio
- PHM $10.00
- WST $38.47
- Revenue Growth
- PHM 5.04
- WST 2.90
- 52 Week Low
- PHM $88.07
- WST $187.43
- 52 Week High
- PHM $149.47
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- PHM 55.56
- WST 58.07
- Support Level
- PHM $131.38
- WST $254.35
- Resistance Level
- PHM $139.69
- WST $264.06
- Average True Range (ATR)
- PHM 3.77
- WST 5.88
- MACD
- PHM -0.86
- WST 0.41
- Stochastic Oscillator
- PHM 37.28
- WST 66.99
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.